| Original language | English (US) |
|---|---|
| Pages (from-to) | 2536-2537 |
| Number of pages | 2 |
| Journal | Leukemia and Lymphoma |
| Volume | 61 |
| Issue number | 10 |
| DOIs | |
| State | Published - Aug 23 2020 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
Claudio Galvao de Castro, Lauro Jose Gregianin, Jan A. Burger
Research output: Contribution to journal › Letter › peer-review
8
Scopus
citations